Clinical Assessment of the Efficacy of Amy Check Versus Osstell Regarding the Accuracy of Implant Stability Measurements When Inserted With Graftless Closed Sinus Lifting: A Randomized Controlled Clinical Trial

NCT07827950 | Completed

• 1 other identifier: Suez Canal University 904/2024
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of the study is to compare clinically the efficacy of Amy check device versus Osstell device in evaluating the implant stability of implants placed simultaneously with transcrestal sinus lifting.

Conditions

Missing Tooth/Teeth

Outcome Measures

Primary Outcomes (1)

• implant stability

  12 months

Study Arms (2)

control group

ACTIVE COMPARATOR

Other: Implant with sinus lifting

Group A (Study Group)

ACTIVE COMPARATOR

Other: Implant with sinus lifting

Interventions

Implant with sinus lifting OTHER

* In Group (A): healing abutment is placed and the implant stability is measured using the Amy check device. * In Group (B): smart peg is attached to the implant and the implant stability is measured using the Osstell device then the smart peg is detached and healing abutment is placed.

Group A (Study Group); control group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient age should be \> 18 years of age.
• Patients included are ASA I and ASA II.
• Both males and females will be included in the study.
• Patients with need of tooth replacements in the maxillary premolar and molar area where the residual alveolar bone height ranges from 4-7 mm. 5)Compliance with all requirements in the study and signing the informed consent.

You may not qualify if:

• Patients with immunological diseases or diseases affecting bone healing.
• Patients suffering from uncontrolled systemic diseases.
• Patients with active acute infection related to the planned implant site, maxillary sinusitis or pathosis.
• Patients with parafunctional occlusal habits.
• Patients with bad oral hygiene.
• Patients who are alcohol and drug abusers.
• Patients who smoke.

Sponsors & Collaborators

• Suez Canal University: lead
• Misr International University: collaborator

Study Sites (1)

Suez Canal University

Cairo, Egypt

Location

MeSH Terms

Conditions

Anodontia

Interventions

Drug Implants

Condition Hierarchy (Ancestors)

Tooth Abnormalities; Stomatognathic System Abnormalities; Stomatognathic Diseases; Tooth Diseases; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Delayed-Action Preparations; Dosage Forms; Pharmaceutical Preparations

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant professor

Study Record Dates

• First Submitted: September 14, 2026
• First Posted: September 18, 2026
• Study Start: February 1, 2025
• Primary Completion: July 28, 2025
• Study Completion: August 10, 2025
• Last Updated: September 18, 2026

Record last verified: 2026-09

Locations

EG (1)